5 Questions with Dr. Malcolm Brenner

        As one of cell and gene therapy's premier clinical scientists, Dr. Malcolm Brenner's renowned work and passion has taken him from the collegiate grounds of Cambridge, England to the humid bayous of Houston, Texas. Born and raised in London, Dr. Brenner received both his medical degree and his PhD at the distinguished University of Cambridge. In 1990 he crossed the Atlantic to work at St. Jude Children's Research Hospital in Memphis, Tennessee as the director of the Cell and Gene Therapy Program where he conducted the first human gene therapy studies on bone marrow stem cells – a truly pioneering achievement. Since that time, Dr. Brenner has held a number of positions including President of ISCT from 1999 to 2000 and President of the American Society of Gene Therapy from 2002 to 2003. From Memphis, Dr. Brenner moved 600 miles south west, finding his current home as a full-time faculty member at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital. Over the years, Dr. Brenner has been recognized as a pioneer in cell and gene therapy with a number of accolades that include the American Society for Gene and Cell Therapy Outstanding Achievement Award, Human Gene Therapy's Pioneer Award, the American Society of Hematology Mentor Award, the European Society of Gene and Cell Therapy Outstanding Achievement Award, and most notably being elected as a member of the American Association of Physicians and of the National Academy of Medicine.
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'


        Subscribe to Cytotherapy
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect